Alfred Sallman

Title: Alfred Sallman: Innovator in Pharmaceutical Chemistry

Introduction

Alfred Sallman is a notable inventor based in Bottmingen, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative processes and compounds. With a total of 2 patents, Sallman has demonstrated his expertise and creativity in developing new chemical formulations.

Latest Patents

Sallman's latest patents include a novel process for the preparation of substituted indoles. This invention relates to a unique method for creating compounds where R is a straight-chain C2-C4 alk-1-en-1-yl, along with their salts. Additionally, he has developed novel guanidinium aspartates, specifically the L-arginine salt of N-(D)-{[2-(2,6-dichlorophenylamino)phenyl]acetyl}aspartic acid. This compound exhibits excellent water solubility and a physiologically favorable pH value, making it suitable for various forms of administration.

Career Highlights

Sallman has worked with Ciba-Geigy Corporation, a prominent player in the pharmaceutical industry. His work has contributed to advancements in drug formulation and delivery systems, showcasing his commitment to improving healthcare solutions.

Collaborations

Throughout his career, Sallman has collaborated with esteemed colleagues such as Marc Gerspacher and Gerhard Baschang. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Alfred Sallman's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the field, paving the way for future innovations in drug development.